Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Selective inhibition of CCR7- TEM cells activation by a novel peptide targeting Kv1.3 in a rat EAE model.
Discontinuation of Disease-Modifying Treatment for Multiple Sclerosis
Nephrotic syndrome in multiple sclerosis patients who had undergone long-term interferon β-1b therapy.
Santhera Announces Successful Outcome of Phase III Study with Catena®/Raxone® in Duchenne Muscular Dystrophy
Rituximab in paediatric onset multiple sclerosis: a case series.
Increased Serum Brain-derived Neurotrophic Factor in Multiple Sclerosis Patients on Interferon-β and Its Impact on Functional Abilities.
Long-term daclizumab therapy in relapsing-remitting multiple sclerosis.
Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research
A meta-analysis of whole genome linkage screens in multiple sclerosis.
Receptos initiates clinical trials for S1P1 agonist program, aimed at multiple sclerosis
Management of Fulminant Multiple Sclerosis With Rituximab: A Case Report.
Oral Laquinimod for Multiple Sclerosis Granted Fast Track Status by FDA
Clinical relevance of differential lymphocyte recovery after alemtuzumab therapy for multiple sclerosis.
Sanofi MS drug nears green light after pass-the-parcel marathon
Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome.
Cladribine
Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects.
Cognitive impairment in multiple sclerosis.
Restoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate.
Altered Expression of Oligodendrocyte and Neuronal Marker Genes Predicts the Clinical Onset of Autoimmune Encephalomyelitis and Indicates the Effectiveness of Multiple Sclerosis-Directed Therapeutics.
Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis.
Effect of daclizumab high-yield process in patients with highly active relapsing-remitting multiple sclerosis.
Unusual case of gastroparesis leading to severe gastromegaly with demyelinating disease as a rare cause.
Glatiramer acetate during early pregnancy: A prospective cohort study.
ALSUntangled No. 8: Low dose naltrexone for ALS.

Pages